Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

BACKGROUND: No clinical trial has directly compared nab-paclitaxel/gemcitabine (nab-P/G) with FOLFIRINOX (fluorouracil/leucovorin/oxaliplatin/irinotecan) in metastatic or advanced pancreatic cancer (mPC or aPC). We conducted a systematic review of real-world studies comparing these regimens in the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiorean, Elena Gabriela, Cheung, Winson Y., Giordano, Guido, Kim, George, Al-Batran, Salah-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535755/
https://www.ncbi.nlm.nih.gov/pubmed/31205510
http://dx.doi.org/10.1177/1758835919850367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535755/
https://www.ncbi.nlm.nih.gov/pubmed/31205510
http://dx.doi.org/10.1177/1758835919850367

Ejemplares similares